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The phosphoprotein (P) of bovine respiratory syncytial virus (BRSV) is a multifunctional protein that plays a central role in
transcription and replication of the viral genomic RNA. To investigate the domains and specific residues involved in different
activities of the P protein, we generated a total of 22 deletion and 17 point mutants of the P protein. These mutants were
characterized using an intracellular BRSV-CAT minigenome replication system for the ability to (1) direct minigenome
transcription, (2) direct minigenome replication, and (3) form complexes with nucleocapsid protein (N) and large polymerase
protein (L). These studies revealed that all the regions of P protein except amino acids 41–80 are essential for minigenome
transcription and replication. Interestingly, amino acids 41–60 appeared to contain sequences that negatively regulate
transcription and replication. Analysis of the N- or C-terminal ends indicated that deletion of up to 3 amino acids from the
N- or C-terminus completely ablated the replication, while leaving substantial residual transcription. Single amino acid
substitutions within the N-terminal 4 or C-terminal 13 amino acids showed that substitution at position 2, 4, 234, 236, 238,
240, or 241 was highly inhibitory to both transcription and replication, whereas substitution at position 3 was highly inhibitory
to replication while leaving substantial residual transcription. Substitution of serine residues at the C-terminus indicated that
loss of phosphorylation sites did not appear to have any effect on transcription and replication. Coimmunoprecipitation of
P–N and P–L complexes with P-specific antiserum revealed that substitution mutations at the N- or C-terminus did not affect
binding to N and L proteins, except that substitution mutation at C-terminus position 234, 236, 238, 240, or 241 affected
binding to N protein by 10-fold. © 2001 Academic PressINTRODUCTION
Bovine respiratory syncytial virus (BRSV) is a major
cause of respiratory disease in calves, resulting in sub-
stantial economic losses to the cattle industry
(Bohlender et al., 1982; Stott et al., 1980; Stott and Taylor,
1985). BRSV is an enveloped RNA virus that, along with
human respiratory syncytial virus (HRSV), ovine respira-
tory syncytial virus (ORSV), and pneumonia virus of mice
(PVM), belongs to the subfamily Pneumovirinae of the
family Paramyxoviridae. BRSV and HRSV have similar
gene maps and encode the same constellation of mR-
NAs and proteins and are antigenically related at the
level of nucleocapsid (N), phosphoprotein (P), matrix (M),
and fusion (F) proteins (Lerch et al., 1989; Mallipeddi et
al., 1990). The major antigenic difference between BRSV
and HRSV is in the attachment glycoprotein (G) (Lerch et
al., 1989; Orvell et al., 1987; Taylor et al., 1984).
The genome of BRSV consists of a single-stranded
negative-sense RNA of 15,140 nt which encodes 10 pro-
1 To whom correspondence and reprint requests should be ad-
ressed at the VA-MD Regional College of Veterinary Medicine, Uni-
ersity of Maryland, College Park, MD 20742. Fax: (301) 935-6079.
-mail: ss5@umail.umd.edu.
253teins (Lerch et al., 1989; Mallipeddi et al., 1990). Four
proteins are associated with the genomic RNA to form
the ribonucleoprotein (RNP) complex, namely N, P, the
large polymerase (L) protein, and the transcription anti-
termination factor M2-1. Three proteins are transmem-
brane components of the envelope; namely, F, G, and the
small hydrophobic proteins. The M protein is an inner
virion protein. NS1 and NS2 are nonstructural proteins
that appear to be antagonists of the interferon type I-me-
diated antiviral state (Schlender et al., 2000). In addition,
we have found (our unpublished data) that BRSV has an
M2-2 protein, which is encoded in a second open read-
ing frame (ORF) in the M2 mRNA, as has been described
for HRSV (Bermingham and Collins, 1999; Ahmadian et
al., 2000).
Among the proteins of the RNP, the N protein encap-
sidates the genomic RNA in its entirety and is the most
abundant nucleocapsid-associated protein. The P pro-
tein is a major phosphorylated protein and is the next
most abundant protein of the RNP. The L protein, which
is thought to be the primary enzymatic component of
virus RNA-dependent RNA polymerase, is present in
smaller quantities. The RNP complex mediates transcrip-
tion and replication of viral genome (Collins et al., 1996).
0042-6822/01 $35.00
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254 KHATTAR ET AL.During transcription, gene-start and gene-end signals on
the viral genome are recognized, and 10 capped and
polyadenylated mRNAs are produced. RNA replication,
on the other hand, results in an encapsidated, full-length
antigenomic RNA. It is not completely understood how
the switch between transcription and replication occurs.
One difference between the two processes is that RNA
replication is dependent on encapsidation by N protein,
which is supplied in unassembled form associated with
soluble P protein (Curran et al., 1991; Horikami et al.,
1992).
The P protein is highly conserved among pneumovi-
ruses. The BRSV P protein, which is 241 amino acids
long, has 98, 82, and 38% amino acid sequence identity
with ORSV, HRSV, and PVM, respectively (Barr et al.,
1994; Ling et al., 1995; Mallipeddi and Samal, 1992). A
egion of high-level similarity, spanning residues 128–
84, was located in pneumovirus P proteins (Ling et al.,
995). The N-terminal portion of this region contains a
eptad repeat sequence, which is often involved in the
ormation of a-helices and coiled coils (Ling et al., 1995).
This region might be involved in intra- or intermolecular
interactions. Further, comparison of the amino-proximal
region of BRSV P protein with other pneumovirus P pro-
teins revealed a region of poor homology, which spans
residues 18–127.
The most extensively studied P proteins are those of
the Sendai paramyxovirus (SeV) and vesicular stomatitis
rhabdovirus (VSV). Each of these proteins forms homoo-
ligomers, with that of SeV P reported to be a tetramer
(Tarbouriech et al., 2000) and that of VSV reported to be
a trimer (Gao et al., 1996). Both proteins also form sep-
arate heterooligomers with the N and L proteins and also
associate with the RNP. The L–P oligomer delivers the
polymerase to the RNP and is essential for transcription
and RNA replication. The N–P complex delivers soluble
N protein for encapsidation and is essential for nucleo-
capsid formation and RNA replication. Also, association
of P with the RNP appears to provide an additional
function important for RNA synthesis. Phosphorylation
appears to be critical to the oligomerization and func-
tioning of the VSV P protein (Gao et al., 1996; Hwang et
al., 1999), whereas mutant SeV P protein that lacked the
normal phosphorylation pattern appeared to be fully
functional in recombinant virus (Hu and Gupta, 2000). It is
not clear whether either of these prototype P proteins is
an accurate model for that of BRSV, and they differ in
amino acid length (for example, the two paramyxoviruses
SeV and BRSV have P amino acid lengths of 568 versus
241) and do not share amino acid sequence relatedness.
The RSV P protein is phosphorylated and has been
reported to form a tetramer (Asenjo and Villanueva,
2000). While most of the phosphate might be dispens-
able for P structure and function, a minor component
appears to be essential for oligomerization and RNA
synthesis (Asenjo and Villanueva, 2000; Villanueva et al.,2000). In particular, a phosphorylated form of the P pro-
tein was recently reported to be essential for transcrip-
tion elongation (Dupuy et al., 1999). By analogy to SeV
and VSV, it is likely that the BRSV P protein also forms
complexes in infected cells with the N and L proteins that
play key roles in transcription and replication of the viral
genome. To gain information on the role of different
regions and residues on the BRSV P protein in transcrip-
tion and replication of BRSV, we have made a panel of
deletion and substitution mutants and used a recently
developed BRSV minigenome system to study the effect
of these mutations on transcription and replication. Pro-
tein–protein interactions were studied by coimmunopre-
cipitation using P-specific antiserum. It is evident from
these studies that N- and C- terminal domains of BRSV P
protein play an important regulatory role in transcription
and replication. These studies have also led to the iden-
tification of a domain within the P protein that seems to
act as a negative regulator in transcription and replica-
tion. Additionally, we have identified specific amino acids
within the N- and C-terminal domains, which are re-
quired for transcription and replication.
RESULTS
Mutagenesis strategy
To define regions of the BRSV P protein important for
transcription, replication, and the formation of protein
complexes, we made a panel of 39 P mutants represent-
ing 22 different deletions, or 17 different single or double
amino acid substitutions (Figs. 1 and 2). In one set of
deletion mutations, a segment of 20 amino acids in
length was deleted at intervals of 20 amino acids, span-
ning the entire 241-amino-acid protein. A second set of
deletion mutations was constructed in which 1, 2, 3, 4, 8,
or 13 amino acids were deleted from either the N- or the
C-terminus. We paid particular attention to the termini in
this way because earlier studies with paramyxovirus P
proteins indicated that N- and C- terminal domains of P
protein play an important role in viral RNA transcription
and replication (Curran et al., 1995b; De et al., 2000; Ryan
et al., 1991).
One set of substitution mutations was designed to
individually change amino acids 2, 3, and 4 at the N-
terminus to alanine. The alanine residue was chosen to
substitute a particular residue in order to decrease the
chance of disrupting the secondary structure of the pro-
tein. In addition, single or double substitutions to alanine
were made involving every residue of the C-terminal 13
amino acids of P (residues 229–241). This region was of
particular interest for two reasons. First, the serine res-
idue at position 232 has been implicated as the major
site of phosphorylation (Barik et al., 1995; Villanueva et
al., 1994) and is conserved among the P proteins of
BRSV, HRSV, and ORSV. Second, analysis of the amino
acid sequence of the P protein using the Scan Prosite
in this
a inus (P
255ANALYSIS OF BRSV PHOSPHOPROTEINtool of the ExPASy program (Swiss Institute of Bioinfor-
matics) identified amino acids 229–241 as a potential
EF-hand (Strynadka and James, 1989) calcium-binding
domain (59 229DESSDNDLSLEDF 24139), with the last
10 residues being conserved in both subgroups of HRSV
as well as in ORSV (our unpublished observations). This
site was completely deleted in one of the deletion
FIG. 1. A diagram of the deletion mutants of the BRSV P protein used
cids at the N-terminus (PN), at an internal region (P), or at the C-termFIG. 2. A diagram of the single and double point mutations of the BRSV P p
(K), phenylalanine (F), aspartic acid (D), serine (S), asparagine (N), and leucinmutations shown in Fig. 1 (mutant PCD13). In addition,
as mentioned above, the various single and double
substitutions involved every position of this putative
domain (Fig. 2). We then analyzed the activity of these
P protein mutants in transcription, replication, and
interaction with N and L proteins in a minigenome
system.
study. The names of the mutant P proteins indicate the deleted amino
C), with the remaining sequences shown as the solid bars.rotein used in this study. The substitutions of glutamic acid (E), lysine
e (L) to alanine (A) are shown.
g in We
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256 KHATTAR ET AL.Expression of mutant proteins
To examine expression of these mutant proteins,
HEp-2 cells were transfected with either wild-type or
mutant pTM1-P plasmid together with the pTM1-N and
pTM1-L support plasmids and infected with a recombi-
nant of the modified vaccinia virus strain Ankara that
expresses T7 RNA polymerase (MVA-T7), as described
under Materials and Methods. Expression of the wild-
type or mutant P proteins containing the various dele-
tions was determined by Western blot analysis (Fig. 3).
As described later, expression of the mutants containing
amino acid substitutions was examined by immunopre-
cipitation. Each of the deletion and substitution P mutant
proteins accumulated intracellularly to a level compara-
ble to that of wild-type P protein; thus, the effects de-
scribed later were not due to differences in expression
nor to stability of various mutant P proteins.
Mutations affecting minigenome transcription
We evaluated the ability of the various P protein mu-
tants to participate in transcription of a previously de-
scribed negative-sense BRSV minigenome, BLT delta 7,
FIG. 3. Expression of wild-type or mutant BRSV P proteins in transfe
(MVA-T7) and transfected with plasmids encoding the BLT delta 7 min
mg), N protein (0.4 mg), and L protein (0.1 mg). At 48 h posttransfection,
el under reducing conditions. The separated proteins were probed
ndicated to the right.
FIG. 4. Gene expression by the BRSV-CAT minigenome as detected b
delta 7 minigenome and support plasmids encoding N, L, wild-type P, o
in the legend to Fig. 3. At 48 h posttransfection, cells were harvested
excised spots. The results are expressed as percentage acetylation relative
E, lane 11) as 100%. As negative controls, the cells in lanes 2, 3, and 4 in A did ncontaining the full-length CAT gene. The plasmid encod-
ing BLT delta 7 was cotransfected with the N, P, and L
support plasmids into cells infected with the MVA-T7
virus (Yunus et al., 1998). These conditions reconstitute
BRSV-mediated transcription and replication of the plas-
mid-encoded minigenome. In this study, the M2-1 protein
was not included because a short gene, such as CAT,
could be transcribed with reasonable efficiency in its
absence (Fearns and Collins, 1999). Cells were har-
vested at 48 h posttransfection, and lysates were pre-
pared and subjected to CAT assay to monitor gene ex-
pression (Fig. 4).
We also directly monitored minigenome transcription
and RNA replication by purifying total intracellular RNA
and subjecting it to Northern blot analysis using a neg-
ative-sense CAT-specific RNA probe (Fig. 5). The exper-
iments involving RNA analysis employed a minigenome
designed to express a shortened version of the CAT
mRNA that could be readily separated electrophoreti-
cally from the antigenomic RNA. Specifically, the BLT
delta 7 construct was modified to produce the SK 7
construct, by insertion of a BRSV consensus gene-end
Ep-2 cells. Subconfluent HEp-2 cells were infected with vaccinia virus
e (0.4 mg), wild-type (WT) or mutant BRSV P protein as indicated (0.2
ere harvested and lysates were electrophoresed on a 4–20% gradient
stern blot with P-specific antiserum. BRSV-specific P polypeptide is
ssay. HEp-2 cells were infected with MVA-T7 and transfected with BLT
nt P proteins (indicated at the top) in the same amounts as mentioned
sed for CAT assay, and quantitated by liquid scintillation counting ofcted H
igenom
cells wy CAT a
r muta
, proces
to the positive control containing wild-type P protein (A–F, lane 1, and
ot receive plasmids encoding wild-type P, N, or L proteins, respectively.
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negativ
259ANALYSIS OF BRSV PHOSPHOPROTEINmotif at the BspEI site in the CAT ORF, such that tran-
scription yielded a truncated CAT mRNA of 274 nucleo-
tides, compared to the antigenomic RNA of 955 nucleo-
FIG. 5. The synthesis of positive-sense RNA from the SK 7 minigen
infected with MVA-T7 and transfected with SK 7 minigenome and supp
top) in the same amounts as mentioned in the legend to Fig. 3. Total intra
blotting with a negative-sense CAT riboprobe. Quantitation of RNA in ea
of the positive control reaction containing wild-type P (A–F, lane 1). As
encoding wild-type P, N, or L proteins, respectively.tides (Khattar et al., 2000). In all of the minigenome
experiments, there was a very close correlation betweenthe level of CAT activity and the accumulation of positive-
sense mRNA encoded by the plasmid-supplied minig-
enome (Figs. 4 and 5). As described below and summa-
mplate as detected by Northern blot hybridization. HEp-2 cells were
mids encoding N, L, wild-type P, or mutant P proteins (indicated at the
r RNA was extracted at 48 h posttransfection and analyzed by Northern
e was done using a densitometer and was expressed as a percentage
e controls, the cells in lanes 2, 3, and 4 in A did not receive plasmidsome te
ort plas
cellula
ch lanrized in Table 1 and Fig. 6, the P protein mutations could
be classified into four categories based on their level of
—Cont
e
a
o
260 KHATTAR ET AL.expression of CAT enzyme and mRNA relative to wild
type: (I) 50–100%, (II) 20–50%, (III) 2–20%, and (IV) ,2%.
Most of the mutations greatly reduced or ablated tran-
scription.
As illustrated in Fig. 1, 12 internal deletions of 20 amino
acids each were made throughout the 241-amino-acid P
protein (mutants PD1-20, PD21-40, PD41-60, PD61-80,
PD81-100, PD101-120, PD121-140, PD141-160, PD161-180,
PD181-200, PD201-220, and PD221-241). Deletion of 20
amino acids at the N-terminal (mutant PD1-20), and any
deletion in the region of amino acids 101–241, completely
FIG. 5
T
Classification of BRSV P Protein Mutants Based on the Lev
Category
Relative CAT activity/amount
of CAT RNAb
I Between 50 and 100% WTP,
II Between 20 and 50% PD61
III Between 2 and 20% PD21
IV Less than 2% PD1-2
PD
a HEp-2 cells were infected with vaccinia virus (MVA-T7) and transfe
ncoding BRSV-CAT minigenome and plasmids encoding either wild-typ
nd analyzed for CAT activity by CAT assay or positive-sense CAT RNA
f CAT activity was done by liquid scintillation counting of excised spob The results depicted are the average values calculated from three indepe
of CAT RNA obtained with the wild-type BRSV P protein was taken as 100%.inhibited P protein function as revealed by CAT expres-
sion and mRNA synthesis (Figs. 4A and 5A; Figs. 4B and
5B). Deletion of amino acids 21–40 or 81–100 drastically
reduced CAT activity and mRNA synthesis (Figs. 4A and
5A, lanes 6 and 9), whereas deletion of amino acids
61–80 resulted in a moderate reduction (Figs. 4A and 5A,
lane 8). Interestingly, deletion of amino acids 41–60 of the
P protein increased the CAT activity and mRNA synthesis
by nearly twofold (Figs. 4A and 5A, lane 7). These results
suggest that (i) all regions of the P protein outside of the
region defined approximately by amino acids 41–80 are
inued
AT Activity and Accumulation of Positive-Sense CAT RNAa
Mutants
0, S231A, S232A, S237A, S232&237A, E230A, D233A, D235A, E239A
D3, PND2, PND1, PCD3, PCD1, PK2A, D229A
81-100, PND4, PCD8, PCD4, PF3A, D240A
01-120, PD121-140, PD141-160, PD161-180, PD181-200, PD201-220,
1, PND8, PCD13, PE1A, N234A, L2326A, L238A, F241A
ith plasmid BLT delta 7 (for CAT assay) or SK 7 (for Northern assay)
tant P, L, and N proteins. At 48 h posttransfection cells were harvested
rthern blot analysis using negative-sense CAT riboprobe. Quantitation
AT RNA was done by densitometer.ABLE 1
el of C
PD41-6
-80, PN
-40, PD
0, PD1
221-24
cted w
e or mu
by No
ts or Cndent experiments. In each experiment the CAT activity or the amount
termina
ed repl
261ANALYSIS OF BRSV PHOSPHOPROTEINessential for minigenome transcription and (ii) the region
defined approximately by amino acids 41–60 in the P
protein is not necessary for fully active transcription and,
indeed, appeared to contain sequences that negatively
regulate transcription.
A second set of mutants contained a series of small
deletions at the N- and C-terminal ends of the P protein.
Removal of1, 2, or 3 amino acids from the N-terminus had
a moderate effect (Figs. 4C and 5C, lanes 6, 5, and 4),
whereas removal of 4 or 8 amino acids from the N-
FIG. 6. Classification of BRSV P protein mutants based on the level of
infected with vaccinia MVA-T7 and transfected with plasmid BLT del
minigenome and plasmids encoding either wild-type or mutant P, L, an
quantitation of CAT activity or positive-sense CAT mRNA was done as
the average values calculated from three independent experiments. In
the wild-type BRSV P protein was taken as 100%. (A) The N- and C-
C-terminal substitution mutants. The mutants that preferentially inhibitterminus greatly reduced or completely ablated CAT ex-
pression and mRNA synthesis (Figs. 4C and 5C, lanes 3and 2). Removal of 1 or 3 amino acids from the C-
terminus had a moderate effect (Figs. 4D and 5D, lanes
6 and 5), whereas removal of 4 or 8 amino acids had a
drastic effect on CAT activity and mRNA synthesis (Figs.
4D and 5D, lanes 4 and 3). Removal of 13 amino acids
from the C-terminus completely inhibited P protein func-
tion (Figs. 4D and 5D, lane 2). Thus, very small deletions
from either end of the P protein were only moderately
inhibitory, whereas deletion of 4 or more residues was
highly inhibitory.
tivity and accumulation of positive-sense CAT mRNA. HEp-2 cells were
r CAT assay) or SK 7 (for Northern assay) encoding the BRSV-CAT
teins, as described in the legend to Fig. 3. Cells were processed and
ed in the legends to Fig. 4 or 5, respectively. The results depicted are
xperiment, the CAT activity or the amount of CAT mRNA obtained with
l deletion, N-terminal substitution, and internal deletion mutants. (B)
ication while leaving some transcription are shown with an asterisk.CAT ac
ta 7 (fo
d N pro
describ
each eSubstitution mutations involving the conserved glu-
tamic acid, lysine, and phenylalanine residues present at
262 KHATTAR ET AL.positions 2 (mutant E1A), 3 (mutant K2A), and 4 (mutant
F3A), respectively, of the N-terminus were evaluated for
CAT expression and mRNA synthesis (Figs. 4C and 5C).
At position 2, the change of glutamic acid to alanine was
completely inhibitory (Figs. 4C and 5C, lane 7), whereas,
at positions 3 and 4, the changes of lysine and phenyl-
alanine to alanine reduced minigenome transcription by
4- and 16-fold, respectively (Figs. 4C and 5C, lanes 8 and
9). Thus, even single amino acid substitutions at posi-
tions 2 and 4 were highly inhibitory.
The remaining P protein mutations involved single or
double substitutions within residues 229–241 at the C-
terminus, a region that includes the major phosphoryla-
tion sites, as well as the putative calcium-binding do-
main mentioned above. Interestingly, mutation of the
potential phosphorylation sites at S231, S232, S237, or
S232 and S237 together had little or no effect on CAT
expression or mRNA synthesis (Figs. 4F and 5F). Thus,
phosphorylation at these sites did not appear to be
important for BRSV transcription. Within the 13-amino-
acid sequence of positions 229–241, two substitutions,
namely D229A and D240A, reduced transcription by 3-
and 10-fold, respectively, and four substitutions, namely
N234A, L236A, L238A, and F241A, completely ablated
transcription (Figs. 4D and 5D; Figs. 4E and 5E). Thus,
the amino acids within the C-terminus of P that are
important for transcription are as follows (underlined):
DESSDNDLSLEDF. With the exception of D229, each of
these residues is exactly conserved in both subgroups of
HRSV and in ORSV.
Mutations affecting minigenome replication
We also examined the ability of the mutant P proteins
to support RNA replication. The Northern blots shown in
experiment in Fig. 5 provided detection of antigenomic
RNA in addition to mRNA, permitting evaluation of this
step in RNA replication and direct comparison in the
same gel lane with transcription. As shown in Figs. 5A
and 5B, all the internal deletions except PD41-60 and
PD61-80 were inactive in anti-genome synthesis. Dele-
tion of amino acids 61–80 reduced anti-genome synthe-
sis by twofold (Fig. 5A, lane 8); whereas, deletion of
amino acids 41–60 increased anti-genome synthesis by
approximately twofold (Fig. 5A, lane 7). Thus, the effects
of these mutations on the synthesis of antigenomic RNA
appeared to be the same as for transcription. In partic-
ular, the region which appeared to negatively regulate
transcription had a similar effect on replication. Similarly,
substitution mutations in the C-terminal region of P had
similar effects on the synthesis of antigenomic RNA and
mRNA. Specifically, substitutions at N234, L236, L238,
D240, and F241 were highly inhibitory (Figs. 5D and 5E),
whereas the other substitutions were well tolerated, in-
cluding those at the potential phosphorylation sites S231,
S232, and S237 (Fig. 5F). In contrast, a number of othertypes of mutations severely inhibited the synthesis of
antigenomic RNA while permitting a substantial level of
transcription. For example, deletion of one, two, or three
amino acids from the N-terminus completely ablated the
synthesis of antigenomic RNA, while up to 43% of tran-
scription remained (Fig. 5C). Similarly, deletions of up to
three or four amino acids from the C-terminus (Fig. 5D),
or substitution at position 3 (mutant K2A) (Fig. 5C), com-
pletely ablated the synthesis of antigenomic RNA while
leaving substantial residual transcription. In summary,
many of the mutations in P had similar effects on the
synthesis of antigenomic RNA and mRNA, particularly
the larger deletions within the body of the protein and the
amino acid substitutions near the C-terminus. However,
the synthesis of antigenomic RNA was highly sensitive to
small deletions or point mutations near the termini,
whereas many of these smaller mutations were tolerated
by transcription.
We then examined the ability of P protein mutants to
support the synthesis of negative-sense minigenomic
RNA in the reconstituted system. In this reconstituted
system, minigenomic RNA is synthesized directly from
the transfected plasmid by T7 RNA polymerase, encap-
sidated by plasmid-supplied nucleocapsid proteins, and
replicated by the reconstituted BRSV polymerase. There-
fore, it was necessary to reduce the background of
plasmid-derived minigenomic RNA in order to visualize
the one that was amplified by the BRSV polymerase. This
was done by lysing the harvested cells with nonionic
detergent followed by treatment with micrococcal nucle-
ase (MCN) to destroy unencapsidated RNA, a procedure
that was characterized in detail in previous work
(Peeples and Collins, 2000). The remaining RNAs were
purified and analyzed by Northern blotting with a posi-
tive-sense CAT RNA probe. As can be seen in Fig. 7A,
under these conditions, a background of genomic RNA
was detected in the absence of BRSV polymerase (Fig.
7A, lanes 2 and 3), representing encapsidated plasmid-
derived RNA as well as a possible small amount of
undegraded, unencapsidated, plasmid-derived RNA. The
amount of material in the genomic RNA band was greatly
increased in the presence of the complete polymerase
(Fig. 7A, lane 1), indicating the extent of amplification
mediated by the reconstituted BRSV polymerase. All of
the P mutants described above were analyzed, and the
results for a selection of these mutants are shown in
Figs. 7A–7C.
The effects of the various mutations on the synthesis
of genomic RNA paralleled the effects described above
for antigenomic RNA. For example, all of the deletions of
20 amino acids within the body of the P protein were
highly inhibitory except for PD61-80, which reduced syn-
thesis threefold, and PD41-60, which increased synthe-
sis approximately twofold. Similarly, substitutions within
the C-terminal 13 amino acids that were inhibitory to the
synthesis of antigenomic RNA (and transcription) also
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263ANALYSIS OF BRSV PHOSPHOPROTEINwere inhibitory to the synthesis of genomic RNA, such as
N234A, L236A, L238A, and F241A (Figs. 7B and 7C),
whereas substitutions within this region that were not
inhibitory, or were partially inhibitory, to the synthesis of
antigenomic RNA (or transcription) had the same effect
on the synthesis of genomic RNA, as exemplified by two-
to threefold inhibition associated with D229A (Fig. 7C).
Finally, the mutations in the N- or C-terminus that inhib-
ited the synthesis of antigenomic RNA, but left substan-
tial residual transcription, also inhibited the synthesis of
genomic RNA, such as PCD1 and PND1 (Fig. 7B).
The formation of P–N and P–L complexes
We then investigated the interactions between the P
FIG. 7. The synthesis of negative-sense genome RNA from the SK 7
minigenome template, as detected by Northern blot hybridization.
Transfections were performed as described in the legend to Fig. 3, with
plasmids encoding the wild-type or mutant P proteins, as indicated at
the top. Cells were harvested at 48 h posttransfection, and cells were
lysed and treated with MCN, followed by RNA extraction. RNA was
analyzed by Northern blot hybridization, using positive-sense CAT ri-
boprobe. As controls, the cells in (A), lane 2, did not receive plasmids
encoding P and L proteins and in lane 3 did not receive plasmid
encoding L protein.and the N proteins and between the P and the L proteins
using the BRSV-CAT minigenome system. In experiments
(
wto monitor P–L interactions, the N plasmid was omitted to
facilitate detection and to confirm that the interaction
was specific to these two proteins. In these experiments,
cells were transfected with the minigenome and appro-
priate support plasmids and were infected with the
MVA-T7 virus. Twenty-four hours posttransfection, cells
were incubated in the presence of [35S]methionine for
–8 h and lysates were prepared and subjected to im-
unoprecipitation with polyclonal P-specific antiserum
Figs. 8A–8D). Under these conditions, N protein (Fig. 8A,
ane 3) and L protein (Fig. 8C, lane 3) coprecipitated with
ild-type P protein, indicating P–N and P–L complex
ormation, respectively, in the transfected cells. Similar
omplexes were detected in lysates of BRSV-infected
ells (Fig. 8A, lane 4, and results not shown), indicating
hat they are authentic. In addition, control experiments
n which the N, P, and L proteins were expressed indi-
idually showed that these coimmunoprecipitations were
ot due to nonspecific precipitation of either N or L
rotein, since P-specific antiserum did not precipitate N
rotein (Fig. 8A, lane 2) nor L protein (Fig. 8C, lane 2) in
he absence of P protein. These results confirmed that
mmunoprecipitation of the N or L proteins with P-spe-
ific serum is dependent on interaction of N or L with the
protein.
All the C-terminal or N-terminal substitution mutations
nd the C-terminal deletion of 13 amino acids (PCD13)
ere evaluated for their interactions with N protein (Figs.
A and 8B). Densitometric analysis of coprecipitated N
rotein indicated that the C-terminal substitution mutants
230A, D233A, D235A, and E239A interacted as effi-
iently as wild-type P protein with N protein (Fig. 8A,
anes 5–8), as did all the C-terminal serine and N-termi-
al substitution mutants (Fig. 8A, lanes 9–12 and Fig. 8B,
anes 2–4). In contrast, interaction of C-terminal substi-
ution mutants N234A, L236A, L238A, D240A, and F241A
nd C-terminal deletion mutant PCD13 with N protein
as reduced by 10-fold compared to the wild-type P–N
nteraction (compare lanes 13–18 with lane 3 in Fig. 8A).
nteraction of substitution mutant D229A was reduced by
hreefold compared to the wild-type P–N interaction
compare lane 19 with lane 3 in Fig. 8A). Thus, the ability
f each P protein mutant to interact with the N protein
as directly proportional to its ability to participate in
inigenome transcription and replication, with a single
xception, namely the K2A, which appeared to interact
ith N protein (Fig. 8B, lane 3) and supported a level of
ranscription that was 30% that of wild-type (Fig. 5C, lane
), but which was defective in the synthesis of antigeno-
ic (Fig. 5C, lane 9) or genomic (Fig. 7B, lane 7) RNA.
Next, we analyzed all the substitution mutants and the
eletion mutant PCD13 for interaction with L protein
Figs. 8C and 8D). All these mutants interacted as effi-
iently as wild-type P protein with full-length L proteincompare lanes 4–18 with lane 3 in Fig. 8C and lanes 2–5
ith lane 1 in Fig. 8D).
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264 KHATTAR ET AL.These results indicated that the defect in transcription
FIG. 8. Effect of BRSV P protein substitution and deletion mutations o
positive control or HEp-2 cells (in all the lanes except A, lane 4) were
proteins, as described in the legend to Fig. 3, except that plasmid enc
ells were pulse-labeled at 24 h postinfection or transfection for 4
mmunoprecipitation with P-specific antiserum. Under these conditions
nteraction with the P protein. Immunoprecipitated proteins were separ
ells in lanes 1 and 2 in (A) did not receive plasmids encoding WT N o
lasmids encoding WT L or P proteins, respectively. The molecular
olypeptides are indicated to the right.and replication ability of C-terminal substitution mutants
D229A, N234A, L236A, L238A, D240A, and F241A anddeletion mutant PCD13 was associated with reduced
and P–L interactions. Btu cells (A, lane 4) were infected with BRSV as
cted with the minigenome system components and wild-type or mutant
N protein was omitted from the transfection mixture in (C) and (D). The
with [35S]methionine, and lysates were processed and subjected to
protein (A and B) and L protein (C and D) coprecipitated, due to their
12% SDS–PAGE under reducing conditions. As negative controls, the
teins, respectively, and the cells in lanes 1 and 2 in (C) did not receive
markers in kDa are indicated to the left. BRSV specific N, P, and Ln N–P
transfe
oding
to 6 h
, the N
ated on
r P probinding to N protein, whereas binding to L was unaf-
fected. One other mutation, K2A, was associated with
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265ANALYSIS OF BRSV PHOSPHOPROTEINreduced RNA replication without an apparent effect on
the formation of P–N or P–L complexes.
In addition, the internal deletion of amino acids 41–60
(PD41-60), which increases the transcription and replica-
tion by nearly twofold more than wild-type P protein, was
also evaluated for interaction with N and L proteins. Our
results showed that there is no difference in the level of
interaction of mutant PD41-60 and wild-type P protein
with N and L proteins (compare lane 5 with lane 1 in Figs.
8B and 8D), indicating that increases in transcription and
replication were not due to increased interaction with N
and L proteins.
DISCUSSION
The P protein of nonsegmented negative-strand RNA
viruses is a multifunctional species that is phosphory-
lated, forms homooligomers, forms heterooligomers with
the N and L proteins, and interacts with the RNP (Asenjo
and Villanueva, 2000; Curran et al., 1995a; Das and Ban-
erjee, 1992; Gao et al., 1996; Nishio et al., 1997). The P
rotein associates with free N and L proteins to maintain
hem in soluble form prior to their assembly into, or
nteraction with, the nucleocapsid. The binding of P to
he RNP also appears to be important for RNA synthesis.
n addition, the P protein has a cofactor function for RNA
ynthesis that appears to be separate from its associa-
ion with N, L, or RNP (Bowman et al., 1999; Curran, 1996;
e et al., 2000; Tarbouriech et al., 2000). The P protein of
he paramyxovirus SeV has been studied in considerable
etail, and the sequences important for binding to itself,
o N and L, and to RNP have been mapped. In addition,
sequences important for RNA synthesis by SeV and the
losely related human parainfluenza virus type 3 (HPIV3)
ave been mapped in part (Bowman et al., 1999; De et al.,
2000). However, the SeV and HPIV3 P proteins bear no
structural resemblance to that of BRSV, being much
larger (568 or 602 amino acids, respectively, versus 241)
and lacking sequence relatedness with BRSV P; thus, the
relevance of this information for BRSV was unclear. In
this report, we have prepared a large panel of N-terminal,
C-terminal, and internal deletion and substitution mu-
tants of the BRSV P protein. Using a minigenome system,
we evaluated these mutants for effects on transcription,
replication, encapsidation, and interaction with the N and
L proteins.
The effects of P mutations on intracellular minigenome
transcription were measured by CAT assay and by North-
ern blot analysis. Deletions across most of the P protein
reduced its ability to support minigenome transcription to
less than 2% of wild-type level: specifically, these highly
inhibitory deletions included amino acids 1–20 and 101–
241, as well as deletion of 8 or more amino acids from the
N-terminus. Smaller deletions from either terminus, or
deletions within amino acids 21–100, were tolerated to
varying degrees. Well-tolerated deletions included thoseof up to 3 amino acids from either terminus and deletion
within amino acids 41–80. This latter domain coincides
closely with a region of the P protein that is poorly
conserved among BRSV, the two HRSV subgroups, and
ORSV, namely amino acids 59–80. These findings indi-
cate that the P protein contains a small N-proximal func-
tional domain and a larger C-proximal functional domain
separated by a poorly conserved spacer that is not very
important for P protein function. This modular organiza-
tion is somewhat reminiscent of the P protein of Sendai
virus, although SeV has the additional feature of RNA
editing that provides a mechanism for swapping the
C-terminal C module with that of the V protein. Interest-
ingly, in the case of BRSV, one particular deletion within
this spacer region, namely amino acids 41–60, was as-
sociated with a consistent increase in transcription. It
might be that this region contains a specific negative
regulatory activity. However, analysis of interaction of
amino acid 41–60-deleted P protein with N and L pro-
teins showed that it was not increased compared to
wild-type P protein. In contrast, a negative regulatory
region located in HPIV3 interacted with nucleocapsid
protein greater than 2.5-fold (Zhao and Banerjee, 1995).
Mutants that contained single amino acid substitu-
tions within the N-terminal 4 or C-terminal 13 amino
acids were also analyzed. This showed that substitution
at residues E2, F4, N234, L236, L238, D240, or F241 was
highly inhibitory to transcription. It was interesting that
deletions PND2, PCD1, and PCD3 gave significant CAT
activity and mRNA synthesis yet the amino acid changes
at position 2, 240, and 241 abolished these activities.
These results suggest that changing the amino acids at
these positions may alter the conformation of the P
protein in such a way that polymerase or encapsidation
function of P protein is affected, hence synthesis of
mRNA or CAT activity is abolished. Similar results were
also observed in the interaction studies of N and P
proteins of VSV (Takacs et al., 1993). The loss of the
major phosphorylation site at S232 did not appear to
have any effect on transcription. This is in contrast to the
findings of Barik et al. (1995) and Dupuy et al. (1999), who
provided data that phosphorylation at this site is impor-
tant to activate the P protein for transcription by HRSV in
vitro. However, our results are in agreement with those of
Villaneuva et al. (2000), who also showed that substitu-
tion of S232 had little effect on transcription by an HRSV
minigenome. Thus, the minigenome results indicate that
intracellular transcription by BRSV or HRSV does not
depend on phosphorylation at S232 or S237.
RNA replication was measured by Northern blot anal-
ysis of the intracellular synthesis of antigenomic and
genomic RNA. Comparable results were obtained
whether the synthesis of antigenomic or genomic RNA
was monitored. In addition, most of the mutations had
comparable effects on RNA replication versus transcrip-
tion. Thus, as described above, deletions across most of
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266 KHATTAR ET AL.the P protein were highly inhibitory on both transcription
and RNA replication. However, deletions in the region of
amino acids 41–80 were well tolerated, and deletion of
amino acids 41–60 yielded an increase in RNA replica-
tion, as was described above for transcription. Also, the
C-terminal amino acid substitutions had comparable ef-
fects on transcription and RNA replication. Thus, phos-
phorylation at S232 or S237 appeared to be completely
dispensable for intracellular minigenome RNA replica-
tion.
However, certain mutations had a much more drastic
effect on RNA replication than on transcription. For ex-
ample, whereas deletion of up to 4 amino acids from the
N-terminus left considerable residual transcription activ-
ity, it completely ablated RNA replication. Substitution at
amino acid position 3 (mutant K2A) left considerable
residual transcription, but completely ablated replication.
In addition, deletion of up to four to eight amino acids
from the C-terminus left considerable transcription activ-
ity, but completely ablated replication. Thus, RNA repli-
cation was highly sensitive to deletions at either termi-
nus, whereas transcription accommodated small termi-
nal deletions and at least one substitution.
Analysis of amino acids present in the C-terminal puta-
tive calcium-binding domain (59229DESSDNDLSLEDF24139)
howed that deletion of the whole calcium-binding domain
PCD13) and substitutions at N234, L236, L238, D240, or
241 amino acid impaired RNA transcription and replica-
ion. To determine whether impaired transcription and rep-
ication were due a defect in binding to N and/or L proteins,
nteraction studies were performed. Our results showed
hat binding of all these mutants with N protein was af-
ected by more than 10-fold, whereas the binding to L
rotein was not affected. This might be due to either con-
ormational change or a defect in binding to calcium, as it
as been reported earlier by Ikura (1996) that calcium bind-
ng results in the exposure of hydrophobic surface, allowing
nteraction with target proteins.
In summary, we have identified mutations in phospho-
rotein of BRSV using a minigenome system that affects
ranscription and replication. It would be interesting to
xamine these mutations in an infectious virus using the
everse genetics system, since such a virus may display
haracteristics desirable for an attenuated vaccine or
elp in studying the pathogenesis of BRSV.
MATERIALS AND METHODS
ells, viruses, and antiserum
HEp-2 and bovine turbinate (Btu) cells were grown in
agle’s minimal essential medium (EMEM) supple-
ented with 5% fetal bovine serum. Strain A51908 of
RSV was propagated in Btu cells. Modified vaccinia
irus strain Ankara (MVA) expressing T7 RNA polymer-
se (gift from B. Moss, NIAID, NIH) was propagated in
hick embryo fibroblast cells (Wyatt et al., 1995). HEp-2
p
rells, grown in six-well culture dishes (35-mm-diameter
lates), were used for transfections. For coimmunopre-
ipitation studies, monospecific serum raised against
scherichia coli-expressed P protein was used.
lasmids and the mutants of P gene
Plasmids pTM1-P, pTM1-N, and pTM1-L containing
he BRSV P, N, and L genes (A51908 strain), respectively,
loned downstream of the T7 RNA polymerase promoter
f plasmid pTM-1, have been described previously (Yu-
us et al., 1998). Construction of the BRSV minigenome
LT delta 7 has been described previously (Yunus et al.,
998). Briefly, the BLT delta 7 minigenome contains a
egative-sense copy of the bacterial CAT gene under the
ontrol of BRSV gene-start and gene-end (GE) transcrip-
ion signals and flanked by the leader and trailer regions
f BRSV genomic RNA (Yunus et al., 1998). Its 39 end is
enerated by a self-cleaving ribozyme from the anti-
enome strand of hepatitis delta virus. Construction of
he BRSV minigenome SK 7 has been described previ-
usly (Khattar et al., 2000). Briefly, the cDNA encoding
inigenome SK 7 was constructed from BLT delta 7
DNA by insertion into a unique BspEI site within the
AT sequence of a synthetic DNA containing a consen-
us GE motif of BRSV (Fig. 6). This GE insertion resulted
n the synthesis of a subgenic CAT mRNA of 274 nt by the
K 7 minigenome construct, compared to 745 nt CAT
RNA synthesized by the BLT delta 7 construct. The
74-nt subgenic positive-sense CAT mRNA encoded by
K7 could be easily distinguished from the 955-nt BRSV-
AT positive-sense anti-genome after electrophoresis on
ormaldehyde–1.5% agarose gels.
Site-specific point mutations and amino- and carboxy-
erminal and internal deletions of the P gene of BRSV
ere carried out by a single round of PCR, using the
ethod described by Byrappa et al. (1995). Briefly, 21-mer
rimers were phosphorylated at their 59 ends using T4
olynucleotide kinase (New England Biolabs) at 37°C for
h. Twenty-five picomoles of each phosphorylated inter-
al primer pair was used to amplify 20 ng of plasmid
NA. Fourteen cycles of PCR amplifications were carried
ut with Pfu Turbo DNA polymerase (Stratagene) (1 min
t 94°C, 1 min at 55°C, and 6.5 min at 72°C). All P gene
utants were sequenced in their entirety and confirmed
or correct P protein expression by in vitro transcription
nd translation, using the rabbit reticulocyte lysate sys-
em as described by the supplier (Promega).
ransfections
Transfections were performed as described by Gros-
eld et al. (1995). Briefly, HEp-2 monolayers in six-well
lates were infected with MVA-T7 at an m.o.i. of 5 PFU
er cell and transfected with the following mixture of
lasmids per single well by using Lipofectamine Plus
eagent and Lipofectamine, as described by the supplier
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267ANALYSIS OF BRSV PHOSPHOPROTEIN(Life Technologies): 0.4 mg of either BLT delta 7 minig-
nome or SK 7 minigenome DNA, 0.2 mg of either wild-
ype or mutant pTM1-P, 0.4 mg of pTM1-N, and 0.1 mg of
TM1-L. Five hours later, the transfection medium was
eplaced with EMEM containing 10% fetal bovine serum.
epending on the specific experiment, cells were har-
ested at 48 h posttransfection and processed for West-
rn blot analysis, CAT activity, or Northern blot analysis
r radiolabeled at 24 h posttransfection for immunopre-
ipitation of proteins.
AT assay
Cell pellets from individual wells transfected with BLT
elta 7 minigenome cDNA and all the support plasmids
ere harvested by scraping, separated into two identical
liquots, and pelleted by centrifugation. One of the ali-
uots was resuspended in sodium dodecyl sulfate (SDS)
ample buffer and analyzed by Western blotting with
-specific antiserum. The other aliquot was resuspended
n 200 ml of 0.25 M Tris–HCl (pH 7.5), lysed by three
cycles of freezing and thawing, and clarified by brief
centrifugation in microcentrifuge. Aliquots of the clarified
supernatant were used to determine the total protein
content (with a Pierce protein assay kit), the CAT activity,
using D-threo-[dichloroacetyl-1-14C]chloramphenicol (50
to 60 mCi/mmol) (Amersham) as the substrate, according
to the standard procedure (Gorman et al., 1982). Different
amounts (3 to 20 ml) of the cell extracts were incubated
with radioactive chloramphenicol for 2 h to obtain CAT
activity values in the linear range. Quantitation of the CAT
activity was done by liquid scintillation counting of ex-
cised spots. The values obtained were corrected for the
protein concentration of the cell extract and were ex-
pressed as a percentage of the CAT activity observed for
cells expressing the wild-type P protein.
Western blot analysis
One half of the volume of the total cells harvested from
one well was lysed in a SDS–polyacrylamide gel elec-
trophoresis sample buffer containing b-mercaptoetha-
nol, and lysate representing about 1/20th of one well of
cells was subjected to electrophoresis through a 4–20%
gradient gel, and the separated polypeptides were trans-
ferred to nitrocellulose, using conventional techniques.
BRSV-specific wild-type or mutant P proteins were de-
tected by incubation with P-specific antiserum, followed
by incubation with horseradish peroxidase-labeled goat
anti-rabbit IgG (Kirkgaard and Perry Laboratories), fol-
lowed by peroxidase reaction using 1 component of TMB
membrane peroxidase substrate (Kirkgaard and Perry
Laboratories).
RNA isolation and Northern blot analysisCell pellets from individual wells transfected with SK 7
minigenome cDNA and all the support plasmids wereharvested by scraping, separated into two identical ali-
quots, and pelleted by centrifugation. One of the aliquots
was used for extraction of total intracellular RNA for
Northern blot analysis. The other aliquot was subjected
to micrococcal nuclease digestion before RNA extraction
and Northern blot analysis. RNA was isolated with TRIzol
reagent according to the supplier’s protocol. Depending
on the specific experiment, one-third of the total intracel-
lular RNA, either undigested or micrococcal nuclease
digested (approximately 5–10 mg, representing one-sixth
of the total amount from each well), was electrophoresed
on 0.44 M formaldehyde, 1.5% agarose gel and trans-
ferred to nylon membrane. The RNAs were fixed at 80°C
for 1 h. Prehybridization was performed for 6 h at 65°C
with prehyb/hyb buffer (Quality Biologicals) containing
63 SSC, 53 Denhardt’s solution, 0.5% SDS, and 0.5
mg/ml sheared salmon sperm DNA. Hybridization was
performed overnight under the same conditions with
approximately 2 3 106 dpm of positive-sense or nega-
tive-sense strand-specific CAT riboprobe. To synthesize
these probes, a 672-bp CAT gene, derived from PstI–
XbaI-digested BLT delta 7, was subcloned in pGEM-4Z
vector (Promega), generating plasmid pGEM4Z-CAT.
Negative- or positive-sense CAT riboprobes were syn-
thesized by in vitro transcription of XbaI- or PstI-digested
pGEMZ-CAT DNA. The densitometric analysis of autora-
diographs of Northern blots was carried out using a
densitometer (Molecular Dynamics).
Micrococcal nuclease protection assay
To identify encapsidated RNA, MCN protection assay
was done according to Baker and Moyer (1988). Briefly,
one-half of the cell pellet from one 35-mm well trans-
fected with SK 7 minigenome cDNA and all the support
plasmids was disrupted in 50 ml of RSB (10 mM NaCl, 10
mM Tris, pH 7.5, 1.5 mM MgCl2)–1.0% Triton X-100–0.5%
OC–aprotinin. The clarified cytoplasmic extract (3000 g
or 15 min at 4°C), supplemented with 50 ml of Tris–CaCl2
buffer (10 mM Tris, pH 7.5, 2 mM CaCl2), was incubated
with 6 units of MCN (Roche Molecular Biochemicals) for
30 min at 30°C. The RNA was extracted as described
above.
Radiolabeling of cells and immunoprecipitation
Twenty-four hours after transfection or infection, the
cells were washed and incubated in methionine-free
EMEM for 2 h before labeling with [35S]methionine (100
mCi/ml). After 4–8 h of labeling, the cells were harvested.
The cells were lysed in a buffer containing 50 mM Tris–
HCl (pH 7.5), 150 mM NaCl, and 0.7% Nonidet P-40.
Nuclei were eliminated from the lysate by centrifugation
at 10,000 rpm for 15min at 4°C. The cytoplasmic fractions
were incubated overnight at 4°C with antibodies (P-
specific antiserum, which is preadsorbed with MVA-in-
fected HEp-2 cell lysate). Formalin-fixed killed Staph A
AB
B
B
C
D
D
F
G
G
G
H
H
I
K
M
M
268 KHATTAR ET AL.cells (Gibco BRL), resuspended in 100 mM NaCl–10 mM
Tris, pH 7.5–1 mM EDTA–1% BSA, were added to the
lysate and incubated at 4°C for 2 h. The Staph A cells
were pelleted, and supernatants were removed. The pel-
lets were washed once with Salt Wash A buffer (1.0 M
NaCl, 0.01 M Tris–HCl, pH 7.2, 0.1% vol/vol NP-40) and
two times with Salt Wash C buffer (0.01 M Tris–HCl, pH
7.2, 0.1% vol/vol NP-40). The Staph A cells were then
resuspended in a sample buffer and analyzed by SDS–
polyacrylamide gel electrophoresis. Samples were incu-
bated at 100°C for 5 min prior to loading on SDS–12%
polyacrylamide gel. Densitometric analysis of autoradio-
graphs of polyacrylamide gels was carried out using a
densitometer (Molecular Dynamics).
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